1. Pavlova T.D. Kartashov S.M. Knyazeva A.V. Ovaries cancer complex treatment using radiation therapy. // Ukrainian radiology magazine. -1999. -#1 –p. 64-65.
  2. Kartashov S.M. Knyazeva M.V. Pavlova T.D. Knyazeva A.V. Lipid peroxidation, antioxidant system – connection with the metabolic activity of the tumor and prognosis of the ovaries cancer progress. // Thesis of the second CIS oncology congress with doctors from the US, Europe and Asia. Kiev, 2000. p. 1020
  3. Knyazeva M.V. Kartashov S.M. Knyazeva A.V Some indicators of immune system and biochemical characteristics of tumors in ovaries cancer treatment.
  4. Pavlova T.D. Knyazeva M.V. Dudnichenko A.S. Kartashov S.M. Knyazeva A.V. Use of immune system and biochemical characteristics indicators of tumors patients sick with ovaries cancer for optimization and individualization treatment. // Experimental and clinical medicine. Kharkov -2001 #1 p. 137-140.
  5. Prokopyuk A.V. Knyazeva M.V. Pavlova T.D. According to the question about research to estradiol and progesterone in the pathogenesisa of ovaries cancer. // Fundamental questions of experimental and clinical endocrinology. Kharkov 2005. P. 165-167.
  6. Knyazeva M.V. Kartashov S.M. Knyazeva A.V Prospects of hormones and receptors  research use in diagnostics ovaries cancer. 2003 Dnepropetrovsk. “Science and education” p. 31-33.
  7. Knyazeva M.V. Mikhanovskiy A.A. Prokopyuk A.V. Results of biochemical research in solving questions about neoadjuvant chemotherapy patients with ovaries cancer.  // “Bukovinskiy medical messenger”. Chernovtsy 2005. #2. P. 120-123.
  8.  Knyazyeva M.V., Prokopyuk A.V., Pavlova T.D.   Steroid hormone receptor expression in pathogenesis and prognosis of ovarian cancer  //  5- th Parnas conference. Molecular mechanisms of cellular signaling.- The Ukrainian Biochemical Journal.-Vol.77, N2, 2005 (special issue).-P.189.
  9. M.V. Knyazyeva and A.V. Prokopyuk. Desintegration of collagen metabolism between the various organs as a possible reason for their pathology // The FEBS Journal.-V.272, Supplement 1, 2005.-P. 271-272.
  10. Pavlova T.D. Knyazeva M.V. Prokopyuk A.V. Neoadjuvant chemotherapy influence to the extra polar matrix characteristics patients with common ovaries cancer forms. Materials of XI oncology congress, Sudak, Ukraine, AR Crimea-Kiev 2006, p. 192.
  11. Mikhanovskiy A.A. Prokopyuk A.V. Pavlova T.D. Evaluating the effectiveness of neoadjuvant chemotherapy in patients with ovarian cancer. // Materials of XI oncology congress, Sudak, Ukraine, AR Crimea-Kiev 2006, p. 192.
  12. Prokopyuk A.V Knyazeva M.V. Pavlova T.D. Glycosaminoglycans blood serum in strategy ovarian cancer patients’ treatment in III-IV phase. // International conference of young oncologists. Nowadays problems in experimental and clinical oncology. 2-3 February 2006. P. 69.
  13. Knyazyeva M., Prokopyuk A., Babaeva O. Peculiarities of metabolism of glycosaminoglycans in monitoring of ovarian cancer treatment // The FEBS Journal.-2006.,V.273.-S.1.- P.262.
  14. Knyazyeva M.V. Prokopyuk A.V. Mikhanovskiy A.A. Pavlova T.D Specialties of ovarian cancer III-IV phases  patients’ biochemical blood changes influenced by neoadjuvant chemotherapy. // IV CIS congeress, Baku, Georgia, 2006, p. 297
  15. Pavlova T.D Knyazyeva M.V. Prokopyuk A.V. Oclogynecology. A manual for physicians and gynecologists and obstetricians. // Kharkov, publishing office “Karavella”. 2006, p. 364.
  16. Method of effectiveness ovarian cancer treatment prognosis. // Mikhanovskiy A.A. Knyazyeva M.V. Prokopyuk A.V. Pavlova T.D. Ivanova I.V. // Application for invention # а 200606810 dated 29.06.2006 Patent for invention # 78952,dated  25.04.2007.-#5.
  17. Prokopyuk A.V Knyazeva M.V. Pavlova T.D. Influence of neoadjuvant chemotherapy courses quantity on fractional composition of glycosaminoglycans in serum in patients with ovarian cancer stage III-IV. // Conference materials “Molecular basis and clinical problems with drugs”. Kiev-Oncology. Special release 2006, p. 47.
  18. M.V. Prokopyuk A.V. Mikhanovskiy A.A.  Pavlova T.D. Knyazeva M.V. Kazmiruk O.V. Influence of neoadjuvant chemotherapy courses quantity to US-semiotic characteristics of ovarian cancer stage III-IV. Conference materials “Molecular basis and clinical problems with drugs”. Kiev-Oncology. Special release 2006, p. 48.
  19.  Knyazyeva M.V., Prokopyuk A.V., Babaeva O.I.Ivannikova S.V.Glycosaminoglycans as an instrument in work of molecular machine of connective tissue// The FEBS Journal, 2007.-Vienna, Austria .-V.274.- Supplement1.-P.213.
  20. Knyazyeva M.V., BabaevaO.I., Prokopyuk A.V., Morgun V.A. The effect of stress factor of The connective tissue of different localization// Materials of III International Young Scientist Conference. Biodiversity. Ecology.Adaptation. Evolution.-Odesa.-2007.-P.196.
  21. Prokopyuk A.V Knyazeva M.V. Pavlova T.D. Dynamics of certain cytokines in the serum of III-IV ovarian cancer patients of stages under the influence of the number of courses. // Siberian consultation: medical pharmaceutical magazine – 2007 - #7, p. 72-73.
  22. Knyazyeva M., Prokopyuk A, Fedec O.,  Pavlova T. Peculiarities of biochemical changes in blood serum and postoperative tissues in patients having ovarian cancer at III-IV stages // J. Annales UMCS, Pharmacia.-V.21.,N1.-2008.-61-70.
  23.  Knyazyeva M., Fedec O., Prokopyuk A., Pavlova T. Сhangesin some cytokines and glycosaminoglycan content in patients having ovarian cancer ( in the course of treatment ) //FEBS Journal , 2008 AthensGreece 33rd FEBS Congress .-V.275.- Supplement1.-P.237.
  24. Prokopyuk, A.V. Sukhina O.M. Mikhanovskiy A.A. Kalmikova I.V. Pavlova T.D. Ultrasound features common forms of ovarian cancer in the neoadjuvant chemotherapy // Experimental and clinical medicine. 2008, #2.-p.143-146.
  25. Prokopyuk A.V Knyazeva M.V. Pavlova T.D. Mikhanovskiy A.A. Kazmiruk O.V. Prospects for the study of the immune system in question on the number of courses of neoadjuvant chemotherapy in ovarian cancer stage III-IV // Thesis VIII conference of young oncologists. Kiev, 2007, p. 64
  26. Knyazyeva M., Prokopyuk A,V.  Pavlova T.D. Interconnection CA125 content, total glycosaminoglycan (GAG) and their fractions in the serum of patients with ovarian cancers during treatment. // Conference materials “Actual problems of modern biochemistry and cell biology”. Dnepropetrovsk 2008, p. 30.
  27. Prokopyuk A,V. Morphological changes in the tumor tissues of patients with stage III-IV ovarian cancer depending on the number of courses of neoadjuvant chemotherapy. // Experimental and clinical medicine 2009, #1 .-p..137-140.
  28. Prokopyuk A,V. Analysis of the effectiveness of treatment of patients with ovarian cancer stage III-IV inoperable in the first phase of treatment. // Medicine today and tomorrow. KNMU 2009.-#1.-p.141-143.
  29. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. The use of lipid peroxidation indices in the diagnostic complex operability of patients with ovarian cancer. // Conference thesis “Oxidative stress and free radical pathology”. Sudak, Crimea, Ukraine 2009, p, 70.
  30. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. On the use of cytokines in monitoring the impact of neoadjuvant polichemotherapy in patients with ovarian cancer. // Medical chemistry“. 2009.-Т.11.-#4 .- p.80-82.
  31.  Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D.  The content of glycosaminoglycans (GAG) as  part of a diagnostic complex evaluation of  treatment effect in ovarian cancer stages III-IV // The FEBS Journal, 2010.- GoteborgSweden .-V.277  .- Supplement1.-P.198.
  32. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. Biochemical indicators of connective tissue in the diagnostic sector assess the effectiveness of treatment for ovarian cancer phase III-IV. // Ukrainian biochemistry magazine. 2010.-№4(addition 2).-Т.82.-p. 19-20.
  33. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. Free-radical processes in patients with ovarian cancer stage III-IV and the status of the connective tissue. // Thesis VI international Crimean congress “Oxidative stress and free radical pathology”. -20-29 September 2010.-p.21.
  34. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D.   Significance of biochemical investigations in medicine (according to complex of treatment efficiency evaluation in ovarian cancer ) // The FEBS Journal, 2011.- Torino, Italy .-V.278  .- Supplement1.-P.213.
  35. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. Concerning about the effect of oxidative stress on the efficacy of neoadjuvant chemotherapy III-IV ovarian cancer phase. // Thesis VI international Crimean congress “Oxidative stress and free radical pathology”. -20-29 September 2010.-p.22.
  36. Prokopyuk A,V.  Knyazyeva M.V. Yakovleva N.G. Pavlova T.D. Impact of neoadjuvant chemotherapy (NPHT) for the maintenance of some cytokines in the blood of patients with ovarian cancer (OC) III-IV phases. // Materials of XII oncology conference Sudak, Crimea, Ukraine, 20-22 September 2011.
  37. Prokopyuk A,V.  Knyazyeva M.V.  Pavlova T.D. Concerning the question of criteria for evaluating the effectiveness of treatment of III-IV ovarian cancer phases. Taurian biomedical messenger.- 2012-T.15, #2, Part 2 (58) .- p.177-181
  38. Prokopyuk A,V.  Knyazyeva M.V.  Pavlova T.D. Method of evaluating the effectiveness of treatment for ovarian cancer: Application u 2011 10736 of 06.09.2011. // Patent for Utility Model UA № 72412 dated 28.08.2012 28.08.2012.--#16.
  39. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. Characteristics of a method for evaluating the effectiveness of neoadjuvant chemotherapy in patients with ovarian cancer III-IV phase. Science works digest “Promising innovations in science, education, manufacturing and transport”. Odessa 2012 2012.- Т.27.- p.45-52.
  40. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. A method of evaluating the effectiveness of neoadjuvant chemotherapy in III-IV ovarian cancer patients of phases. // Health as a factor of quality and lifetime of biological species.- Materials digest of the XXXVIII International Research and Practice Conference and the III Stage of the Championship in medicine, pharmaceutics and veterinary  sciences.- IASHE.- London, 2013.- P.46-49.
  41. Prokopyuk A,V.  Knyazyeva M.V.  Pavlova T.D. Prospects for treatment of ovarian cancer phase III-IV. // Taurian biomedical messenger 2013.-Т.16, #2, part.1 (62).- p.190-192.
  42. Knyazyeva M.V. Prokopyuk A,V.  Pavlova T.D. Some approaches to improve the effectiveness of the treatment of ovarian cancer phase III-IV. Topical areas of fundamental and applied researches.- Proceedings of the international scientific-practical conference.-Moscow, March 4-5, 2013.- p.64-68.
  43. Knyazyeva M., Prokopyuk A. Targeting ovarian cancer at the molecular mechanisms level of the treatment efficiency increase // The FEBS Journal, 2013.- St. Petersburg, Russia..-V.280.- Supplement1.-P. 389.
  44. Knyazyeva M., Prokopyuk A., Pavlova T.D. Connective tissue metabolism markers for increase of ovarian cancer efficiency treatment // The FEBS Journal, 2014.- Paris, France..-V.281.- Supplement1.- TUE-378.-P. 565.
  45. Pavlova T.D. Knyazyeva M.V. Prokopyuk A.V. Oncogynecology. (Manual for gynecologists and obstetricians) – 2014, p. 380.
  46. Prokopyuk A,V.  Knyazyeva M.V.  Concerning about the question of criteria for evaluating the effectiveness of neoadjuvant chemotherapy of patients with ovarian cancer III-IV phases. Thesis VIII congress of oncologists and radiologists CIS and Eurasia .-Eurasian Journal of Oncology, #3 (03), 2014.- p.585-586
  47. Knyazyeva M.V. Prokopyuk A.V. Glycosaminoglycans – from abstract knowledge to the use of knowledge in clinical medicine // The FEBS Journal, 2015.- Berlin, Germany.-V. 282.- Supplement1.- P16-009.-P. 276.
  48. Prokopyuk A,V.  Knyazyeva M.V.  Pavlova T.D. Concerning about the question of individualization of treatment of patients with ovarian cancer phase III-IV // Science conference materials . "New methods of diagnosis and treatment of oncology diseases" .- Collection of works.- Kharkov 2015.
  49. Knyazyeva M.V. Prokopyuk A.V. Contribution of clinical biochemistry at improving the effectiveness of treatment with ovarian cancer III IV phases // Proceedings of international science sonference. "The economy, science, education, integration and synergy 'Bratislava-Vienna-Budapest, January 2016-p.95-96.
  50. Prokopyuk A,V.  Knyazyeva M.V. New Treatment for ovarian cancer patients common forms. // Materials of the III International science practical conference. "Questions of Modern Science: problems, trends and prospects» .- CHRONOS, 2016
  51. Knyazyeva M.V. Babaeva O.I. Prokopyuk A.V. Concerning the question on the diagnostic role in the connective tissue of blood parameters in various diseases // Materials of the XIV international science conference. "The development of science in the 21st century" .- publishing office “Znanie” 2016.
  52. Prokopyuk A,V.  Knyazyeva M.V. Some approaches to the individualization of treatment of III-IV ovarian cancer phases. XIII congress of oncologists and radiologists of Ukraine. Ukrainian radiological magazine, (addition 1) 2016, p. 132-133
  53. Prokopyuk V.U. Skibina K.P. Prokopyuk A.V. KozubM.N. Placenta Extract accelerates the recovery of sexual and reproductive function after chemotherapy in the experiment (a pilot study). // Materials of the XIII congress of oncologists and radiologists. Ukrainian radiological magazine. Addition 1, 2016 p.159.